Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Abeona Therapeutics Inc. | 4 | 1 | 1 | 0 | €3.90 | €33.73 | 764.831% |
| Syros Pharmaceuticals Inc. | 6 | 1 | 1 | 0 | €4.62 | €13.60 | 194.318% |
| MannKind Corp. | 8 | 0 | 1 | 0 | €4.15 | €6.03 | 45.241% |
| Incyte Corp. | 12 | 2 | 2 | 0 | €52.92 | €78.42 | 48.190% |
| TG Therapeutics Inc. | 22 | 4 | 2 | 0 | €15.15 | €28.06 | 85.220% |
| AbbVie Inc. | 22 | 0 | 2 | 0 | €144.38 | €175.11 | 21.285% |
| Iovance Biotherapeutics Inc. | 21 | 3 | 2 | 0 | €8.31 | €25.20 | 203.429% |
| Stoke Therapeutics Inc | 15 | 1 | 2 | 0 | €12.70 | €21.00 | 65.383% |
| Codexis Inc. | 6 | 2 | 2 | 0 | €3.14 | €8.36 | 165.878% |
| Krystal Biotech | 18 | 0 | 2 | 0 | €146.35 | €179.60 | 22.716% |
| Akero Therapeutics Inc | 14 | 0 | 2 | 0 | €16.90 | €38.19 | 125.998% |
| Celldex Therapeutics | 11 | 1 | 2 | 0 | €32.60 | €56.62 | 73.672% |
| Biocryst Pharmaceuticals | 9 | 0 | 2 | 0 | €6.08 | €11.05 | 81.697% |
| Natural Alternat. | 19 | 1 | 2 | 0 | €5.95 | - | - |
| Intra-Cellular Therapies Inc. | 25 | 0 | 2 | 0 | €61.00 | €79.55 | 30.417% |
| Alnylam Pharmace. | 36 | 0 | 2 | 0 | €138.50 | €236.30 | 70.612% |
| Adverum Biotechnologies Inc. | 7 | 0 | 2 | 0 | €1.38 | €5.60 | 305.913% |
| Medpace Holdings Inc | 11 | 0 | 2 | 0 | €355.90 | €419.64 | 17.909% |
| Corcept Therapeutics Inc. | 12 | 0 | 3 | 0 | €29.22 | €36.17 | 23.800% |
| Cara Therapeutics Inc. | 11 | 1 | 3 | 0 | €0.55 | €4.62 | 734.869% |
| Regeneron Pharmaceuticals Inc. | 36 | 1 | 3 | 0 | €896.00 | €958.32 | 6.955% |
| Esperion Therapeutis.Inc. | 15 | 0 | 3 | 0 | €2.11 | €8.55 | 305.000% |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €26.60 | €47.53 | 78.677% |
| Precision BioSciences Inc | 9 | 0 | 3 | 0 | €0.35 | €10.38 | 2881.839% |
| Zoetis Inc. A | 23 | 1 | 3 | 0 | €156.42 | €200.06 | 27.898% |